{
    "status": "OK",
    "copyright": "Copyright (c) 2025 The New York Times Company. All Rights Reserved.",
    "response": {
        "docs": [
            {
                "abstract": "Intensifying pressure stands to upend business models heavily dependent on raising prices.",
                "web_url": "https://www.nytimes.com/2016/11/09/business/dealbook/valeants-struggles-are-a-bad-omen-for-the-entire-industry.html",
                "snippet": "Intensifying pressure stands to upend business models heavily dependent on raising prices.",
                "lead_paragraph": "A disastrous quarter for Valeant Pharmaceuticals is a bad sign of things to come for a whole industry.",
                "source": "The New York Times",
                "multimedia": [],
                "headline": {
                    "main": "Valeant\u2019s Struggles Are a Bad Omen for the Entire Industry",
                    "kicker": "Breakingviews",
                    "content_kicker": null,
                    "print_headline": null,
                    "name": null,
                    "seo": null,
                    "sub": null
                },
                "keywords": [
                    {
                        "name": "subject",
                        "value": "Drugs (Pharmaceuticals)",
                        "rank": 1,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Valeant Pharmaceuticals International Inc",
                        "rank": 2,
                        "major": "N"
                    },
                    {
                        "name": "subject",
                        "value": "Company Reports",
                        "rank": 3,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Amgen Inc",
                        "rank": 4,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "AmerisourceBergen Corp",
                        "rank": 5,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Endo International PLC",
                        "rank": 6,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Express Scripts Inc",
                        "rank": 7,
                        "major": "N"
                    }
                ],
                "pub_date": "2016-11-08T18:38:54+0000",
                "document_type": "article",
                "news_desk": "Business",
                "section_name": "Business Day",
                "subsection_name": "DealBook",
                "byline": {
                    "original": "By Robert Cyran",
                    "person": [
                        {
                            "firstname": "Robert",
                            "middlename": null,
                            "lastname": "Cyran",
                            "qualifier": null,
                            "title": null,
                            "role": "reported",
                            "organization": "",
                            "rank": 1
                        }
                    ],
                    "organization": null
                },
                "type_of_material": "News",
                "_id": "nyt://article/05a6aa58-e683-5ca1-b0a1-07c71db79a5b",
                "word_count": 381,
                "uri": "nyt://article/05a6aa58-e683-5ca1-b0a1-07c71db79a5b"
            }
        ],
        "meta": {
            "hits": 1,
            "offset": 0,
            "time": 6
        }
    }
}